IRD Q3 2022 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena

IRDOpus Genetics, Inc.

$346M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$5M

Net Income

-$5M

EPS (Diluted)

$-0.22

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$493,000

Balance Sheet

Total Assets

$15M

Total Liabilities

$3M

Stockholders' Equity

$12M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$489,000	-100.0%
Gross Profit	$0	$489,000	-100.0%
Operating Income	-$5M	-$4M	-7.2%
Net Income	-$5M	-$4M	-7.1%